Hiren V. Patel

Hiren V. Patel

Auto-generated profile, based on publicly available information

Hiren V. Patel

Department of Urology, The Ohio State University, Columbus, Ohio

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 August 2024 in Journal of Medical Internet Research
Verified
Journal Article
Open access
KLKevin Danis Li
Kevin Danis Li
AFAdrian M Fernandez
Adrian M Fernandez
RSRachel Schwartz
Rachel Schwartz
NRNatalie Rios
Natalie Rios
MCMarvin Nathaniel Carlisle
Marvin Nathaniel Carlisle
BBBenjamin N Breyer
Benjamin N Breyer
Background: Large language models including GPT-4 (OpenAI) have opened new avenues in health care and qualitative research. Traditional qualitative methods are time-consuming and require expertise to capture nuance. Although large language models have demonstrated enhanced contextual understanding and inferencing compared with traditional natural language processing, their performance in qualitative analysis versus that of humans remains unexplored. Objective: We evaluated the effectiveness of GPT-4 versus human researchers in qualitative analysis of interviews with patients with adult-acquired buried penis (AABP). Methods: Qualitative data were obtained from semistructured interviews with 20 patients with AABP. Human analysis involved a structured 3-stage process—initial observations, line-by-line coding, and consensus discussions to refine themes. In contrast, artificial intelligence (AI) analysis with GPT-4 underwent two phases: (1) a naïve phase, where GPT-4 outputs were independently evaluated by a blinded reviewer to identify themes and subthemes and (2) a comparison phase, where AI-generated themes were compared with human-identified themes to assess agreement. We used a general qualitative description approach. Results: The study population (N=20) comprised predominantly White (17/20, 85%), married (12/20, 60%), heterosexual (19/20, 95%) men, with a mean age of 58.8 years and BMI of 41.1 kg/m2. Human qualitative analysis identified “urinary issues” in 95% (19/20) and GPT-4 in 75% (15/20) of interviews, with the subtheme “spray or stream” noted in 60% (12/20) and 35% (7/20), respectively. “Sexual issues” were prominent (19/20, 95% humans vs 16/20, 80% GPT-4), although humans identified a wider range of subthemes, including “pain with sex or masturbation” (7/20, 35%) and “difficulty with sex or masturbation” (4/20, 20%). Both analyses similarly highlighted “mental health issues” (11/20, 55%, both), although humans coded “depression” more frequently (10/20, 50% humans vs 4/20, 20% GPT-4). Humans frequently cited “issues using public restrooms” (12/20, 60%) as impacting social life, whereas GPT-4 emphasized “struggles with romantic relationships” (9/20, 45%). “Hygiene issues” were consistently recognized (14/20, 70% humans vs 13/20, 65% GPT-4). Humans uniquely identified “contributing factors” as a theme in all interviews. There was moderate agreement between human and GPT-4 coding (κ=0.401). Reliability assessments of GPT-4’s analyses showed consistent coding for themes including “body image struggles,” “chronic pain” (10/10, 100%), and “depression” (9/10, 90%). Other themes like “motivation for surgery” and “weight challenges” were reliably coded (8/10, 80%), while less frequent themes were variably identified across multiple iterations. Conclusions: Large language models including GPT-4 can effectively identify key themes in analyzing qualitative health care data, showing moderate agreement with human analysis. While human analysis provided a richer diversity of subthemes, the consistency of AI suggests its use as a complementary tool in qualitative research. With AI rapidly advancing, future studies should iterate analyses and circumvent token limitations by segmenting data, furthering the breadth and depth of large language model–driven qualitative analyses.

1 May 2022 in Cell Chemical Biology
Verified
Journal Article
Open access
MLMichael Li
Michael Li
HPHiren V. Patel
Hiren V. Patel
ACArmand B. Cognetta
Armand B. Cognetta
TSTrever C. Smith
Trever C. Smith
IMIvy Mallick
Ivy Mallick
JSJessica Seeliger
Jessica Seeliger
The identification and validation of a small molecule’s targets is a major bottleneck in the discovery process for tuberculosis antibiotics. Activity-based protein profiling (ABPP) is an efficient tool for determining a small molecule’s targets within complex proteomes. However, how target inhibition relates to biological activity is often left unexplored. Here, we study the effects of 1,2,3-triazole ureas on Mycobacterium tuberculosis (Mtb). After screening ∼200 compounds, we focus on 4 compounds that form a structure-activity series. The compound with negligible activity reveals targets, the inhibition of which is functionally less relevant for Mtb growth and viability, an aspect not addressed in other ABPP studies. Biochemistry, computational docking, and morphological analysis confirms that active compounds preferentially inhibit serine hydrolases with cell wall and lipid metabolism functions and that disruption of the cell wall underlies biological activity. Our findings show that ABPP identifies the targets most likely relevant to a compound's antibacterial activity.

1 April 2024 in Journal of Urology
Verified
Journal Article
Open access
JSJoshua Sterling
Joshua Sterling
JSJay Simhan
Jay Simhan
BFBrian of Colorado Flynn
Brian of Colorado Flynn
PRPaul Rusilko
Paul Rusilko
WFWagner A. França
Wagner A. França
DNDmitriy Nikolavsky
Dmitriy Nikolavsky
The treatment of urethral stenosis after a combination of prostatectomy and radiation therapy for prostate cancer is understudied. We evaluate the clinical and patient-related outcomes after dorsal onlay buccal mucosal graft urethroplasty (D-BMGU) in men who underwent prostatectomy and radiation therapy. A multi-institutional, retrospective review of men with vesicourethral anastomotic stenosis or bulbomembranous urethral stricture disease after radical prostatectomy and radiation therapy from 8 institutions between 2013 to 2021 was performed. The primary outcomes were stenosis recurrence and development of de novo stress urinary incontinence. Secondary outcomes were surgical complications, changes in voiding, and patient-reported satisfaction. Forty-five men were treated with D-BMGU for stenosis following prostatectomy and radiation. There was a total of 7 recurrences. Median follow-up in patients without recurrence was 21 months (IQR 12-24). There were no incidents of de novo incontinence, 28 patients were incontinent pre- and postoperatively, and of the 6 patients managed with suprapubic catheter preoperatively, 4 were continent after repair. Following repair, men had significant improvement in postvoid residual, uroflow, International Prostate Symptom Score, and International Prostate Symptom Score quality-of-life domain. Overall satisfaction was +2 or better in 86.6% of men on the Global Response Assessment. D-BMGU is a safe, feasible, and effective technique in patients with urethral stenosis after a combination of prostatectomy and radiation therapy. Although our findings suggest this technique may result in lower rates of de novo urinary incontinence compared to conventional urethral transection and excision techniques, head-to-head comparisons are needed.

17 August 2021 in Cancers
Verified
Journal Article
Open access
PDF file
SDSai Krishnaraya Doppalapudi
Sai Krishnaraya Doppalapudi
ZLZev Leopold
Zev Leopold
Akshay ThaperAkshay Thaper
Akshay Thaper
AKAlain Kaldany
Alain Kaldany
KCKevin Chua
Kevin Chua
ESEric A. Singer
Eric A. Singer
Patients with advanced or malignant renal cell carcinoma at the time of diagnosis have historically had a poor prognosis. Immunonologic agents have significantly altered the therapeutic landscape and clinical outcomes of these patients. In this review, we highlight recent and upcoming clinical trials investigating the role of immunotherapies in clear cell RCC. In particular, we emphasize immunotherapy-based combinations, including immune checkpoint inhibitor (ICI) combinations, neoadjuvant, and adjuvant ICI, and ICI agents combined with anti-VEGF therapy.

7 January 2022 in Clinical Genitourinary Cancer
Verified
Journal Article
Closed access
HPHiren V. Patel
Hiren V. Patel
SKSinae Kim
Sinae Kim
ASArnav Srivastava
Arnav Srivastava
BSBrian M. Shinder
Brian M. Shinder
JSJoshua Sterling
Joshua Sterling
ESEric A. Singer
Eric A. Singer

1 January 2022 in Urology
Verified
Journal Article
Closed access
TOTimothy K. O'ROurke
Timothy K. O'ROurke
MGMartus Gn
Martus Gn
HPHiren V. Patel
Hiren V. Patel
CFChristina Fakes
Christina Fakes
NJNyasia Jones
Nyasia Jones
SESammy E. Elsamra
Sammy E. Elsamra